Ipswich Investment Management Co., Inc. Apellis Pharmaceuticals, Inc. Transaction History

Ipswich Investment Management Co., Inc.

  • $419 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022
SELL
$30.74 - $49.16 $684,426 - $1.09 Million
-22,265 Closed
0 $0
Q3 2021

Oct 07, 2021
BUY
$31.4 - $69.84 $88,391 - $196,599
2,815 Added 14.47%
22,265 $734,000
Q2 2021

Aug 05, 2021
BUY
$40.9 - $64.9 $795,505 - $1.26 Million
19,450 New
19,450 $1.23 Million

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Ipswich Investment Management Co., Inc. Portfolio

Follow Ipswich Investment Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email